BFRGHealthcare · Health Information ServicesBFRG Stock Forecast: BullFrog AI Holdings, Inc. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 37 of 100 as at 22 Aug 2026 — in the lower half.
BFRG stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores BullFrog AI Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Growth (99): Sales and profits are climbing, and climbing faster than before.
Value (6): The shares cost a lot relative to the profits and assets behind them.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
BFRG stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on BFRG, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 26 July 2021 | Bernstein | Upgrade | Market Perform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BFRG appears on the weeks it earns a place.
BFRG analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
BullFrog AI Holdings, Inc. (BFRG) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- −0.9×
- Price / sales
- 92.6×
- Price / book
- 3.1×
- EV / EBITDA
- −0.9×
Cheaper than 82% of US stocks
Cheaper than 4% of US stocks
Cheaper than 34% of US stocks
Cheaper than 66% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- —
- Operating margin
- −5273.5%
- Net margin
- 18.8%
Higher than 3% of US stocks
Higher than 81% of US stocks
- Return on equity
- −149.4%
- Return on assets
- −79.9%
- Dividend yield
- 47.7%
Higher than 9% of US stocks
Higher than 4% of US stocks
Higher than 97% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
BFRG vs competitors
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own BullFrog AI Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about BFRG stock
How does Ticker Nerd's model rank BFRG?
As at 22 Aug 2026, BullFrog AI Holdings, Inc. ranks 37 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (99 of 100).
What is the BFRG stock forecast for 2030?
No analyst covering BullFrog AI Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BFRG are extrapolating price history, which says nothing about the business.
How has BFRG stock performed over the past year?
BullFrog AI Holdings, Inc. returned -51.0% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
What does BullFrog AI Holdings, Inc. do?
Bullfrog AI Holdings Inc. is a digital biopharmaceutical company that leverages artificial intelligence and machine learning to analyze complex datasets in medicine and healthcare.
About BullFrog AI Holdings, Inc.
Bullfrog AI Holdings Inc. is a digital biopharmaceutical company that leverages artificial intelligence and machine learning to analyze complex datasets in medicine and healthcare. It offers bfLEAP, an analytical AI/ML platform designed to process preclinical and clinical data for biotechnology and pharmaceutical companies, identifying high-value patient subgroups and optimizing drug development and clinical trials. The company also provides bfPREP, a data preparation tool that harmonizes raw biomedical data into AI-ready formats, and bfARENAS, a scenario-based decision engine for generating risk-balanced R&D portfolio recommendations. Bullfrog AI Holdings Inc. supports precision medicine by uncovering treatment-effect heterogeneity and biomarkers, as demonstrated in applications like pancreatic cancer analytics and collaborations with partners in oncology trials. Founded in 2017 and headquartered in Gaithersburg, Maryland, it operates at the intersection of computational biology and AI to accelerate drug discovery, enhance clinical outcomes, and reduce development costs through explainable AI, graph analytics, and advanced modeling techniques.
CEO Mr. Vininder Singh · 9 employees · United States · https://www.bullfrogai.com